🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now online in NDT Optimal Glucocorticoid Therapy in Lupus Nephritis 🧐The review examines different dosing strategies, including IV pulse and oral regimens, and presents evidence of their efficacy and safety. ▶️academic.oup.com/ndt/article-ab…

Big day — our JAMA review on ADPKD is out today! 📢 Grateful to the JAMA editorial team for their partnership in shaping this into a high-impact resource for clinicians. If you manage patients with Polycystic Kidney Disease, we hope you’ll find it valuable.

A recent study shows promise in rituximab for managing difficult-to-treat podocytopathies, offering hope for improved remission rates and reduced reliance on traditional immunosuppressants. bit.ly/KN1703-03 Alejandro Garcia-Rivera Harish Seethapathy #ASNKidneyNews

🫘Approach to a patient with bilateral renal cysts jamanetwork.com/journals/jama/… JAMA

In our most recent paper, we have evaluated the integrate safety of Avacopan in the Phase II and III program. We found reductions in the AE rate, SAE rate, infections AE rate and no increased risk of hepatic toxicity! acrjournals.onlinelibrary.wiley.com/doi/full/10.10… #300 on PubMed for me!

Now open access in NDT SGLT2 inhibition for pts with ADPKD – closing the evidence gap 🧐The lack of potent treatment modalities in ADPKD, the use of SGLT2i in this patient population would be of major interest. ▶️academic.oup.com/ndt/article/do…

Now open access in NDT Cardio-Kidney Outcomes for Combined vs Monotherapy with Finerenone or SGLT2i in pts with CKD 🧐Combined therapy with finerenone and SGLT2i is associated with less MAKE and all-cause mortality in CKD patients ▶️academic.oup.com/ndt/article/do…

🎥Watch Dr Laura Labriola present the NDT publication: Infectious complications associated to buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up oup.cloud.panopto.eu/Panopto/Pages/…

We are pleased to announce the publication of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children. Read the News Release: kdigo.co/NS-in-Children… Read the Guideline in Kidney International: kdigo.co/Nephrotic-Synd… Download the Guideline:

New in CJASN 📢 Our meta-analysis of 66 CKD trials shows both acute & chronic GFR slope independently predict clinical outcomes Findings support 3-year total slope as the optimal surrogate endpoint for CKD trials ASN Publications: doi.org/10.2215/CJN.00…

Malnutrition is common yet often overlooked in advanced CKD patients ⚠️. In this study, we showed it affects over 10% of hospitalized cases and is linked to higher death rates, longer stays, and greater costs ⚰️⏳💰. Severe malnutrition rose from 4.2% in 2016 to 5.5% in 2021

✍️ Sign the Int Society of Nephrology petition: ow.ly/jNNt50TLOrR+ #KidneyHealthMatters #WHA78

Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy academic.oup.com/ndt/article-ab… NDT Hans-Joachim Anders

Early control of proteinuria is associated with lower kidney failure risk; in FSGS levels <1.5 g/g associated with good kidney outcomes at 10 years. bit.ly/JASN0610 #ASNJASN

♦️La LIR fête ses 50 ans le 14 juin à Louvain-la-Neuve ! ♦️Conférence, repas & concert 🎶 Réserve ta place 👉 [email protected] - 0470/ 64 33 00

🫘✨Pathophysiology of PGNMID doi.org/10.3390/cells1… NDT Hans-Joachim Anders

🤰Prepregnancy assessment & counseling in ADPKD patients #ADPKDpatients #PregnancyCare #ADPKD #kidney #Fetalrisk #Medications kireports.org/article/S2468-… KIReports

C3G and Ig-MPGN—treatment standard doi.org/10.1093/ndt/gf… ➡️The authors review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of C3G and Ig-MPGN

Ten tips for an OncoNephrology clinic! A must read! Another strong work Dr Elena-Bianca Barbir, MD ! Mayo Clinic Nephrology American Society of Onconephrology CKJ #onconephrology

💊Evidence for drugs in heart failure in presence of CKD bit.ly/434spfa AJKD